Zyprexa Class Action Suit -

[Guest guest]

*Press Release* Source: & Waichman, LLP

& Waichman and & London File First Nationwide Class

Action Lawsuit Against Eli Lilly and Company on Behalf of all Persons

Residing in the United States Who Used Zyprexa

Monday April 19, 1:34 pm ET

& Waichman and & London Have Received Over Two Thousand

Zyprexa Case Inquiries

NEW YORK, April 19 /PRNewswire/ -- & Waichman, LLP

(www.yourlawyer.com <http://www.yourlawyer.com>) and & London

LLP announce the filing of the first nationwide class action lawsuit

against Eli Lilly and Company (NYSE: LLY

<http://finance.yahoo.com/q?s=lly & d=t> - News

<http://finance.yahoo.com/q/h?s=lly>) on behalf of all persons residing

in the United States who used Zyprexa. The lawsuit was filed on April

16, 2004 in the United States District Court for the Eastern District of

New York. Zyprexa is currently the most popular atypical antipsychotic

medication and is Eli Lilly and Company's best-selling pharmaceutical.

Zyprexa has been linked to serious side effects including diabetes,

hyperglycemia and pancreatitis. For information on Zyprexa side effects

and this class action lawsuit please visit www.zyprexa-side-effects.com

<http://www.zyprexa-side-effects.com>.

The class action lawsuit seeks relief for Zyprexa patients who have

already been diagnosed with side effects as well as compensation for

medical testing for all patients who have used Zyprexa in the United

States. Three plaintiffs who have been diagnosed with serious injuries

have been named in the lawsuit. All of the plaintiffs developed diabetes

after taking Zyprexa and one plaintiff developed pancreatitis. &

Waichman has received over two thousand Zyprexa inquiries from

individuals claiming they have been injured.

Last year, the FDA requested that Eli Lilly and Company update its

product labeling for Zyprexa to include a warning about hyperglycemia

and diabetes. Additionally, the British Medical Control Agency and the

Japanese Health and Welfare Ministry have both warned about the risk of

diabetes in patients who are prescribed Zyprexa. In 2002, a study at

Duke University showed a connection between Zyprexa and diabetes. This

study documented nearly 300 cases of diabetes in people using Zyprexa.

Zyprexa was approved for the treatment of schizophrenia in 1996 and for

the treatment of bipolar mania in 2000. It is part of a new generation

of antipsychotics known as atypicals, which include Seroquel, Risperdal,

Abilify, Clozaril, and Geodon. Ironically, the primary advantage of the

newer atypical antipsychotic medications was supposed to be a lower

incidence of side effects than the conventional antipsychotics

introduced in the 1950s (Haldol, Thorazine, Prolixin, Navane, Stelazine,

Trilafon, and Mellaril). More information on Zyprexa side effects is

available at www.zyprexa-side-effects.com. Current and former Zyprexa

users can visit this site to request a free legal evaluation. For more

information on & Waichman, LLP please visit

http://www.yourlawyer.com or call 1-800-LAW-INFO.

Contact:

Krangle, Esq.

& Waichman, LLP

1-800-LAW-INFO (1-)

http://www.yourlawyer.com

dkrangle@...